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Glomerulonephritis induced in sheep by immunization with
human glomerular basement membrane
PER BYGREN, JORGEN WIESLANDER, and DIcK HEINEGARD
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Glomerulonephritis induced in sheep by immunization with human
glomerular basement membrane. The specificity of the anti-glomerular
basement membrane (GBM) antibodies in experimental nephritis in
sheep (Steblay's nephritis) was studied and compared with the specifity
of antibodies in human anti-GBM nephritis (Goodpasture's syndrome).
Sheep were injected monthly with isolated human GBM and antibody
reactivities with isolated human and sheep GBM proteins were quanti-
fied with ELISA. Expectedly, the sheep had high titers of antibodies
against several human GBM antigens. These antibodies remained for
the most part in the circulation. In contrast, circulating antibody levels
against sheep GBM antigens remained low for a long period of time, but
a significant and progressive increase coincided with the development
of acute nephritis, These antibodies accumulated in the kidneys of the
nephritic sheep and could be eluted from diseased kidneys. They
represent auto-antibodies immunologically cross—reacting with antigens
of both sheep and human GBM. The specificity of auto-antibodies
eluted from the kidneys was analyzed by immunoblotting and ELISA.
The major populations reacted with one subunit, termed M2, of the
globular domain of collagen IV. The same subunit contains the major
antigen in Goodpasture's syndrome. It is concluded that the M2 subunit
of the globular domain of collagen IV is recognized by IgG antibodies
that primarily bind to the glomerular basement membrane in both
Steblay's nephntis and Goodpasture's syndrome, indicating that it is a
main nephritogen in both diseases.
Autoimmune glomerulonephritis due to production of anti-
body against glomerular basement membrane antigens was
discovered experimentally by Steblay, who induced fatal gb-
merulonephritis in sheep by repeated injections of isolated
heterobogous glomerular basement membrane (GBM) sus-
pended in adjuvant [1, 2]. Characteristic linear binding of sheep
IgG along the GBM could be shown by immunofluorescence
staining. Glomerulonephritis could be induced in healthy sheep
both by passive transfer of serum antibodies and antibodies
eluted from the kidneys of nephritic sheep [1—3] and by cross—
circulation [4]. The pathogenetic role of the antibodies was thus
established. Similarly it was shortly thereafter discovered that
Goodpasture's syndrome in humans (glomerulonephritis and
lung hemorrhage) is induced by anti-GBM antibody with the
characteristic linear pattern of immunoglobulin deposition
along the gbomerular basement membrane, demonstrable in
kidney biopsies [5, 6].
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Basement membranes are complex structures containing
many potential immunogens that can induce an autoimmune
response [7]. The major element is collagen IV which is
composed of three chains (alpha 1 and alpha 2, type IV) with
N-terminal, partly collagenous regions (7S domains), C-term-
inal noncollagenous globular domains (NC1 domains), and with
an intervening major collagenous portion having a triple helical
structure with interruptions, which are pepsin—sensitive [8]. In
addition basement membranes contain the cell attachment
protein laminin [9], entactin [10], and small amounts of proteo-
glycans [11]. GBM preparations will also contain small amounts
of filtered plasma proteins and cell—derived constituents [7].
Recent research has shown that the antibodies in patients
with Goodpasture's syndrome are directed against epitopes
present in the collagenase—resistant globular domains of colla-
gen IV [12—14] or more precisely, in a monomeric subunit,
termed M2, of the globular domain [15]. Earlier studies in our
laboratory indicated that the circulating antibody response in
the artificially—induced sheep disease might be broader than in
spontaneous human disease, but the nephritogens were not
characterized at that time and eluted antibodies were not
studied [16]. The present study, that was initiated to character-
ize these antigens and the tissue bound antibodies, indicates
that one major probable nephritogen in the sheep model for
antibody mediated glomerubonephritis is indeed very similar to
that in Goodpasture's syndrome.
Methods
Induction of glomerulonephritis
Three one—and—a—half—year—old female sheep were immu-
nized with 5 mg of lyophilized human glomerular basement
membrane (H-GBM) suspended in saline and homogenized with
an equal volume of Freund's Complete Adjuvant. Injections
were done at several locations subcutaneously in the neck.
Booster doses with 5 mg of H-GBM in Freund's Incomplete
Adjuvant were given once a month over periods of five to
thirteen months. Blood samples were drawn at intervals, at
least monthly, and sera were analyzed for creatinine concen-
trations and used in immunological studies. Renal biopsy spec-
imens were prepared and analyzed histopathologically and by
immunofluorescence microscopy. In one sheep extensive his-
topathological studies of most organ systems were performed.
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Laboratory methods
Serum creatinine was analyzed according to Heinegârd and
Tiderström [17]. Sheep IgG concentrations in serum and eluates
were assayed by single radial immunodiffusion according to
Mancini, Carbonara and Heremans [18]. Protein concentrations
were determined according to Lowry et al [19].
Sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE) was done as described by Laemmli [20], using 6 to
22% gradient gels.
Immunoblotting was performed as described by Burnette
[21]. Proteins separated on SDS-PAGE were transferred by
electrophoresis to nitrocellulose papers (Bio Rad Laboratories,
Richmond, Virginia, USA). Bound proteins were immuno-
stained by incubation of the papers overnight with serum or
eluates from sheep followed by a one hour incubation with
swine anti-sheep IgG, labelled with horseradish peroxidase
(Dako, Copenhagen, Denmark). The peroxidase activity was
visualized using the histochemical substrate 3,3 '-diaminobenzi-
dine—tetrahydrochloride (Fluka AG, Switzerland) [221.
Enzyme linked immunosorbent assay (ELISA)
ELISA was performed essentially as described before [23,
241, but the conditions used for coating were varied with the
antigen. Antigens solubilized from GBM with bacterial colla-
genase as well as purified globular domains of collagen IV, and
its isolated subunits Ml, M2, and M3 were coated, 0.1 ig/ml, in
6 M guanidine-HC1, 0.05 M Tris-HC1, pH 7.5. Antigens solubil-
ized with pepsin were coated, 0.5 igIml, in 0.1 M acetic acid.
Pre-immune sera or eluates from normal sheep kidneys were
used as negative controls. Longitudinal serum samples were
analyzed on one immunoplate for each animal and antigen
preparation, to avoid day to day variability with ELISA.
Inhibition experiments were performed by pre-incubating the
diluted sera or eluates overnight at 4°C with the antigens (0 to
100 tg proteinlml) to be tested for their capacity to inhibit in the
assay. Pre-incubated samples were then transferred to microti-
ter plates coated with the different antigens and analyzed as
described elsewhere [23, 241.
Preparation of GBM antigens
Human and sheep GBM used for antigen preparations were
isolated by sieving of kidney cortex and sonication of glomeruli
as described before [24]. Proteinase inhibitors were included in
all preparative steps, that is 5 mivi N-ethylmaleimide, 5 mM
benzamidine-HC1, 25 m 6-amino—hexanoic acid, 10 mM
EDTA, 1 mii phenylmethansulfonyifluoride. Human GBM
used for immunization was, however, prepared without use of
proteinase inhibitors.
Crude human and sheep GBM antigens were solubilized
using bacterial collagenase (CLS, Worthington, Freehold, New
Jersey, USA) which had been purified by the procedure de-
scribed by Lee—Own and Anderson [25]. Digestion was carried
out at 37°C, 16 hours with human or sheep GBM suspended in
0.05 M Hepes buffer, pH 7.45 with 0.01 m calcium chloride
and protease inhibitors, omitting EDTA, as described for the
preparation of particulate GBM.
Pepsin—resistant human and sheep GBM collagen fragments
were prepared as described before [16, 23]. In short, human and
sheep GBM, respectively, were solubilized with pepsin. Type
IV collagen triple helical fragments were precipitated with
sodium chloride at acid pH and at neutral pH [16], essentially as
described by Kresina and Miller [26] and Sage, Woodbury and
Bornstein [27].
The globular domain (NC 1) of collagen IV was isolated from
crude collagenase digests by a procedure involving ion ex-
change chromatography on DEAE cellulose followed by mo-
lecular sieving on Sephacryl S-200 [12, 28].
Monomeric subunits, Ml, M2 and M3 of the globular domain
were isolated from bovine GBM by reversed phase HPLC [15].
The 7S domain of collagen IV was isolated from human
placenta according to Risteli et al [29].
Purified laminin was obtained from a basement membrane
producing tumor of mice, that is, the Engelbreth—Holm—Swarm
(EHS) sarcoma.
Elution of immunoglobulins from the kidneys
Kidney cortex (5 g of wet weight) from a normal sheep and
from each of the nephritic sheep was homogenized and washed
20 times each with 50 ml of buffer, 0.05 M Tris-HC1, 0.15 M
sodium chloride, pH 7.5 including proteinase inhibitors as
described for the preparation of GBM. Insoluble material (1.27
to 1.79 g wet weight) was eluted with 20 ml of ice cold buffer,
0.1 M glycine, 0.5 M sodium chloride, pH 2.8 for 10 minutes and
then with fresh buffer, pH 2.2, for 10 minutes. Supernatants
were immediately adjusted to pH 7.4 to 7.8 with 3 M Tris-HC1.
The pH 2.8 and pH 2.2 eluates from each kidney were pooled
and proteins were precipitated with 50% (saturated) ammonium
sulphate. The precipitate was dissolved in 1.5 ml, 0.05 M
Tris-HC1, 0.15 M sodium chloride, 0.05% sodium azide, pH 7.5
and then dialysed against the same buffer.
Results
Case histories
Two of the three sheep (I and II, Table 1) developed rapidly
progressive renal failure, documented by a progressive increase
of serum creatinine levels, after five and 11 monthly injections
of human particulate GBM (sheep I shown in Fig. 1). The third
sheep (III, Table 1) developed proteinuria but serum creatinine
levels remained constant. This sheep was sacrificed after 14
monthly injections of GBM. At autopsy the kidneys of all sheep
were enlarged and showed peteccie. Other organs, including the
lungs, appeared normal. Histopathological studies of the renal
lesions revealed extracapillary proliferative glomerulonephritis
in all glomerulae of sheep I and II, but focal segmental mesan-
gial glomerulonephritis accompanied by focal sclerosis in sheep
III. Immunofluorescence staining demonstrated a linear fixation
of IgG and C3 along the glomerular basement membranes in all
three sheep. According to these criteria, then, the three animals
had developed an anti-GBM antibody glomerulonephritis. Most
organs of sheep II were taken to histopathological studies,
which disclosed moderate inflammatory cell infiltrates in the
spleen and lymph nodes. The cervical lymph nodes, draining
the sites of injections of GBM, had hyperplastic lymph follicles.
The lungs showed occasional foci of granulomatous inflamma-
tory changes. All other organs, except the kidneys, were nor-
mal. Proteins in urine were measured monthly in sheep II and
III. Significant proteinuria was found to develop concurrent
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Table 1. Induction and course of anti-GBM nephritis in sheep immunized with lyophilized particulate human GBM
Immunization schedule .
Development of uremia
(serum creatinine >300 Renal morphology Deposition ofInitial dose Freunds Booster dose Freunds
complete adjuvant incomplete adjuvant moliter/l Light microscopy sheep IgG
Sheep I 5 mg 5 mg x 5 months 6 months Extracapillary GN
(100% crescents)
Linear, GBM
Sheep II 5 mg 5 mg x 10 months Ii months Extracapillary GN
(100% crescents)
Linear, GBM
Sheep III 5 mg 5 mg x 14 months no uremia Fokal GN, sclerosis
(moderate)
Linear, GBM
1-
Fig. 1. Relation between disease activity (serum creatinine) and anti-
GBM antibody reactivities in sheep I, immunized with particulate
human GBM. Symbols are; (A) serum creatinine mo1/liter; (•) anti-
bodies against human GBM antigens solubilized with bacterial colla-
genase; (0) antibodies against globular domains of human collagen IV;
() antibodies against globular domains of sheep collagen IV.
with the rapid increase of the serum creatinine concentration in
sheep II and during the last month in sheep III.
Circulating serum antibodies
The three sheep had produced high titers of antibodies
against several components of GBM. Collagenous components,
liberated by pepsin digestion of human GBM as well as non-
collagenous components, liberated by collagenase digestion of
human GBM, reacted strongly in ELISA (data not shown).
Better indications of the presence of circulating antibodies with
particular specificity was obtained by strong reactions in
ELISA against purified GBM constituents, that is the globular
domain of human collagen IV from GBM, laminin from the
mouse EHS sarcoma and 7S domain from human placenta (Fig.
2). Interestingly, titers against collagenous (pepsin resistant)
and noncollagenous (collagenase resistant) sheep GBM proteins
(not shown in the figure) and against isolated globular domains
of sheep collagen IV (Fig. 1) were very low during the period of
immunization. The titers, however, increased concurrently
with serum creatinine in the two animals which developed
rapidly progressive glomerulonephritis (Fig. 1).
Cross—reactivity of antibodies eluted from the kidneys
If auto-immunity has a role in heterologously induced sheep
nephritis one would expect that autoantibodies, that is, anti-
body populations with specificity against sheep GBM epitopes
would accumulate in the kidneys and be depleted in the
circulation. Linear binding of sheep IgG along the GBM of the
nephritic sheep and the low titers of anti-sheep GBM antibodies
found in serum indicated that such an accumulation of specific
auto-antibodies may occur. In support, antibodies could be
recovered from the kidneys by elution at acid pH. The yields of
eluted sheep IgG, quantified according to Mancini, Carbonara
and Heremans [18] were 40 ig (sheep I), 250 g (sheep II) and
100 g (sheep III) per g wet weight kidney tissue.
Titration experiments of sera and eluates showed that anti-
bodies with specificity for sheep GBM components were pref-
erentially bound in the kidneys (Fig. 3). Based on IgG levels,
reactivities against human GBM components were very similar
for eluate and serum, but the eluate showed a 50 to 200 times
stronger reaction with sheep GBM than did the serum.
Further experiments using competitive ELISA showed that
antibody populations present in the eluates cross—reacted with
collagenase—resistant and, partly, with pepsin—resistant anti-
gens of both human and sheep GBM (results found in sheep I
shown in Fig. 4). These results indicate that antibody popula-
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Fig. 2. Enzyme—linked immunosorbent assay of serum antibodies at
the time of sacrifice in three sheep immunized with particulate human
GBM. Serum dilutions of 1:20,000.
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Fig. 5. Enzyme—linked immunosorbent assay of antibodies eluted from
kidney cortex of three sheep with anti-GBM nephritis, induced by
immunization with human GBM.
tions, cross—reacting with both human and sheep antigens, were
the ones that had accumulated in the kidneys of the sheep.
Fine spec jficity ofantibodies eluted from kidneys
Eluted immunoglobulins reacted with high titers against
globular domains of human collagen IV and with considerably
lower titers against human 7S domains and laminin (Fig. 5). The
specificities of the eluted antibodies were further investigated
by immunoblotting experiments. Sheep GBM components,
solubilized by digestion with bacterial collagenase, were sepa-
rated by electrophoresis on SDS-PAGE. The proteins were
then transferred electrophoretically to nitrocellulose papers and
immunostained with gammaglobulins eluted from the kidneys of
the three nephritic sheep. In addition, for control, transblotted
proteins were immunostained with antibodies from a patient
with Goodpasture's syndrome. Eluates from nephritic sheep
almost exclusively stained human and sheep GBM proteins
identified as monomeric and dimeric peptides derived from the
globular domain of collagen IV. The staining pattern using
antibodies from the human patient was identical, whereas an
eluate from a normal sheep showed no staining (Fig. 6).
Antibodies from Goodpasture patients react only with mono-
meric and dimeric subunits, termed M2 and D 2, of the globular
domain [15]. Antibodies eluted from the kidneys of the three
sheep were tested in ELISA for their reactivity with the
different monomeric subunits (Ml ,M2,M3) isolated from bovine
GBM [15]. Interestingly, the eluates from all three sheep
reacted mainly with the M2 subunit of the globular domain (Fig.
7). Bovine Ml, M2 and M3 were used because of ease of
preparation and availability. Indirect evidence, that sheep glob-
ular domains also contain these Ml, M2 and M3 subunits was
obtained by inhibition and immunoblotting experiments. Thus
the reactivity of specific rabbit antisera against bovine Ml, M2
and M3 could each be completely inhibited using sheep globular
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Fig. 3. Titration of antibodies eluated from the kidney cortex of a
sheep with anti-GBM nephritis, induced by repeated immunizations
with particulate human GBM. Antibody reactivity (A 450) in kidney
eluates (•) and serum (0) expressed per weight IgG.
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Fig. 4. Competitive enzyme—linked immunosorbent assay: Antibodies
eluted from kidney cortex of sheep I, immunized with human GBM,
were preincubated with solubilized GBM antigens and then tested for
residual reactivity with different antigens by ELISA. Coated antigens
are: collagenase—resistant human (H-GBM:CR) and sheep (S-GBM:CR)
antigens, and Pepsin—resistant human (H-GBM:PR) and sheep (S-
GBM:PR) antigens. Inhibiting antigens are: (GBM:CR) sheep (•) and
human (0) collagenase—resistant GBM antigens, and (GBM:PR) sheep
(•) and human (0) pepsin—resistant GBM antigens.
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domains as an antigen in competitive ELISA (not shown).
Furthermore, these antibovine Ml, M2 and M3 antisera stained
collagenase—resistant sheep GBM products on immunoblotting
having the mobility of globular domain monomers and dimers
on SDS-PAGE (not shown). It was also shown, that the re-
activity of a Goodpasture serum with M2 could be completely
inhibited using purified sheep globular domain monomers as an
antigen.
In conclusion, the immunostaining experiments, the solid
phase binding assay (ELISA) and the inhibition experiments
showed, that a major population of antibodies in eluates from
kidneys of nephritic sheep recognized the same antigen, present
in both human and sheep GBM, as did antibodies from patients
with Goodpasture's syndrome.
Discussion
Although there is general agreement that antibody induces
the disease in different forms of anti-GBM nephritis, there is
controversy as to the fine specificity of these nephrotoxic
antibodies [29]. We have recently shown that a major antibody
population in patients with Goodpasture's syndrome recognizes
a specific antigen, termed Goodpasture antigen [12]. The
epitope(s) was (were) subsequently shown to be localized in one
of the subunits (M2) of the globular domain of collagen IV [15].
In the present study, sheep that were immunized with heterol-
ogous (human) GBM produced an antibody population that
recognized the same antigen (M2) of GBM. Several features
indicated that these antibodies were autoreactive and the ones
responsible for the development of nephritis.
The sheep responded to immunization with human GBM by
developing a nephritis that appeared to run a two—phase course.
No nephritis was evident for a long time although the serum had
high titers of antibodies to heterologous (human) GBM anti-
gens, shown by ELISA. In the second phase an augmented
response to the challenge occurred, indicated by accelerating
renal damage with rapidly increasing serum creatinine levels.
The antibody titers against several human GBM antigens also
increased progressively and hypergammaglobulinemia and pro-
teinuria became prominent. The response to homologous
(sheep) antigens was different. Only low levels of serum anti-
bodies were found in the first phase, but in the last few days of
culminating disease, an increase of the titers in serum was
observed. A similar phenomenon has been described to occur
after nephrectomy in both animals and man [30]. There are two
possible explanations for the increase of circulating antibody in
the final stage. First, with advancing damage renal plasma flow
will decrease and glomerular capillary areas will successively
be eliminated. Secondly, an augmented general antibody syn-
thesis may include auto-antibodies. Available antigenic sites
may then become saturated and antibodies will remain in
circulation. In support large amounts of anti-sheep GBM anti-
bodies could be eluted from the kidneys. Titration of serum and
eluates by ELISA indicated that antibodies against homologous
(sheep) antigens, presumably auto-antibody, had been more
efficiently eliminated from the circulation and bound in the
kidneys than had antibodies against heterologous (human)
antigens (Fig. 3). Antibodies eluated from the kidney of the
nephritic sheep reacted both with human and sheep GBM
antigens by ELISA. Further studies using competitive ELISA
showed that the reactivities with sheep antigens could be
inhibited completely with either human or sheep GBM prod-
ucts. Eluates thus contained populations of antibodies, that
cross—reacted with antigenic determinants found in both human
and in sheep GBM. Eluted antibodies furthermore immuno-
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Fig. 6. Immunoblotting: similar reactivity of antibodies from a patient
with Goodpasture's syndrome (patient) and antibodies eluted from
kidney cortex of three nephritic sheep (I,!! and III) that were immunized
with human GBM. An eluate from a non-immunized sheep showed no
reaction (control).
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Fig. 7. Enzyme—linked immunosorbent assay of antibodies eluted from
kidney cortex of three sheep (1,2,3) with anti-GBM nephritis and a
non-immunized control (0). Theantigens tested were different subunits
(Ml, M2 and M3) of the globular domain of bovine collagen IV.
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stained digestion products of human and sheep GBM with the
same mobility on SDS-PAGE, again confirming their cross—re-
activity with heterologous and homologous GBM determinants.
The fact that immuno-staining was observed with proteins
derived from the globular domain of human, bovine and sheep
collagen IV and that antibodies from a patient with Good-
pasture's syndrome stained identical proteins provides strong
indication, that the major nephritogen in Steblay nephritis and
human Goodpasture's syndrome is the same. This hypothesis
was further strengthened by results obtained by ELISA using
isolated subunits of the globular domain of collagen IV as
antigens. Both sheep antibody and Goodpasture antibody re-
acted best with the M2 subunit (Fig. 6).
Based on results with indirect immunofluorescence micros-
copy, it has previously been suggested that the antibodies in
Steblay nephritis and Goodpasture's syndrome are similar [31],
since antibodies eluted form the kidneys of nephritic sheep
reacted in the same locus as did Goodpasture antibodies.
Moreover, the sheep antibody inhibited the reaction of Good-
pasture antibody with GBM [311. The present study, in support,
provides definite chemical evidence that Steblay and Good-
pasture antibodies recognize the same GBM antigen.
Steblay observed, that the nephrotoxic antibodies in the
sheep model were neither species nor organ specific. Indirect
immunofluorescence microscopy showed that antibodies eluted
from the kidneys of nephritic sheep reacted with basement
membrane of all species and organs tested [32, 33]. Adsorption
of eluates with sheep or human GBM or lung basement mem-
brane preparations, removed the antibodies. Immunization of
sheep with either human or sheep glomerular or human (but not
sheep) lung basement membrane induced identical diseases
[33]. The most likely explanation to these findings is that the
antibodies react with the nephritogenic M2 subunit of collagen
IV, which is a normal component of several basement mem-
branes [7, 14].
It is not known why the GBM is a primary target or why the
antibodies only cause nephritis in sheep while lung involvement
is frequent in human disease. It has recently been demonstrated
[28], that the epitope reacting with Goodpasture antibodies is
sequestered in the hexameric globular domain of collagen IV.
The epitope can be exposed by dissociation of the hexamers by
treatment with guanidine-HC1 of dilute acid in a reversible
process [28]. It is conceivable, then, that some interference
with the organisation of basement membrane components is a
pre-requisite for antibody binding also in vivo. Furthermore,
variable contents of globular domains and of unmasked epi-
topes in different basement membranes, may determine the in
vivo localization of auto-antibody.
In the present study the sheep, in addition to the anti-M2
antibodies, produced small amounts of auto-antibody (that is,
kidney—binding antibody) reactive with purified Ml, M2 and
laminin, which are normal components of basement mem-
branes. Similarly, anti-laminin antibodies are occasionally
found in patients with Goodpasture's syndrome [14, 34].
Antibodies against the 7S domain of collagen IV were present
in serum but only in low amounts in eluates of the kidneys of the
three sheep. These antibodies, therefore, probably had no role
in the disease.
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